Director/PDMR Shareholding

RNS Number : 7566D
Benchmark Holdings PLC
21 February 2020
 

21 February 2020

BENCHMARK HOLDINGS PLC
("Benchmark" or the "Company" or the "Group")

PDMR Shareholding

The Company announces, further to the announcement made on 30 January 2020, that the following persons discharging managerial responsibilities (PDMRs) for the purposes of Article 19 of the Market Abuse Regulation (EU 596/2014) participated in the Placing and/or Open Offer (the "Fundraising").

Name

Number of existing Ordinary Shares

Number of Placing Shares subscribed for

Number of Open Offer shares subscribed for and awarded

Number of Ordinary Shares now held

Percentage of Enlarged Share Capital now held

Peter George

1,000,000

1,250,000

68,219

2,318,219

0.35%

Septima Maguire

-

250,000

-

250,000

0.04%

Susan Searle

98,125

100,000

-

198,125

0.03%

Hugo Wahnish

275,000

75,000

-

350,000

0.05%

Yngve Myhre

400,000

200,000

-

600,000

0.09%

Kevin Quinn

60,929

25,000

-

85,929

0.01%

Alex Raeber

200,000

-

7,658

207,658

0.03%

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities.

 1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Peter George (Executive Chairman)

Septima Maguire (Chief Financial Officer)

Susan Searle (Non Executive Director)

Hugo Wahnish (Non Executive Director)

Yngve Myhre (Non Executive Director)

Kevin Quinn (Non Executive Director)

Alex Raeber (Chief Scientific Officer)

2

 

Reason for the notification

 

a)

 

Position/status

 

 

See 1(a) above

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Benchmark Holdings plc

b)

 

LEI

 

 

2138001UQHM4VZGXUJ19

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares

 

 

ISIN: GB00BGHPT808

 

b)

 

Nature of the transaction

 

 

Subscription for new ordinary shares pursuant to the Placing and/or Open Offer

 

c)

 

Price(s) and volume(s)

 

 

Director/ PDMR

Price(s)

Volume(s)

Peter George

Septima Maguire

Susan Searle

Hugo Wahnish

Yngve Myhre

Kevin Quinn

Alex Raeber

40 pence

40 pence

40 pence

40 pence

40 pence

40 pence

40 pence

1,318,219

250,000

100,000

75,000

200,000

25,000

7,658

 




d)

 

Aggregated information

- Aggregated volume

 

- Price

 

- Aggregated total

 

 

 

Director/ PDMR

Aggregated volume

Price(s)

Aggregated total

Peter George

Septima Maguire

Susan Searle

Hugo Wahnish

Yngve Myhre

Kevin Quinn

Alex Raeber

1,318,219

250,000

100,000

75,000

200,000

25,000

7,658

 

40 pence

40 pence

40 pence

40 pence

40 pence

40 pence

40 pence

£527,287.60

£100,000.00

£40,000.00

£30,000.00

£80,000.00

£10,000.00

£3,063.20

e)

 

Date of the transaction

 

 

19 February 2020

f)

 

Place of the transaction

 

 

London Stock Exchange, AIM

 

 

-Ends-


Benchmark Holdings plc

Tel: 020 3696 0630



Ivonne Cantu, Investor Relations Director


Rachel Aninakwah, Communications




Numis

Tel: 020 7260 1000

Freddie Barnfield, Duncan Monteith (NOMAD)


James Black (Corporate Broking)




MHP


Katie Hunt / Reg Hoare /Alistair de Kare-Silver 

  Tel: 020 3128 8742   

benchmark@mhpc.com


 

 

About Benchmark

Benchmark's mission is to enable food producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), sea lice treatments, training and data management tools. Find out more at www.benchmarkplc.com

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFSIFSILFII
UK 100

Latest directors dealings